EP2444416A1 - Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène - Google Patents

Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène Download PDF

Info

Publication number
EP2444416A1
EP2444416A1 EP11003842A EP11003842A EP2444416A1 EP 2444416 A1 EP2444416 A1 EP 2444416A1 EP 11003842 A EP11003842 A EP 11003842A EP 11003842 A EP11003842 A EP 11003842A EP 2444416 A1 EP2444416 A1 EP 2444416A1
Authority
EP
European Patent Office
Prior art keywords
seq
dxs
polypeptide
sequence
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11003842A
Other languages
German (de)
English (en)
Inventor
Philippe Hugueney
Eric Duchene
Didier Merdinoglu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genoplante Valor SAS
Original Assignee
Genoplante Valor SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genoplante Valor SAS filed Critical Genoplante Valor SAS
Priority to EP11003842A priority Critical patent/EP2444416A1/fr
Priority to DK11787597.1T priority patent/DK2630157T3/en
Priority to AU2011317859A priority patent/AU2011317859B2/en
Priority to PCT/EP2011/005283 priority patent/WO2012052171A1/fr
Priority to BR112013009807-4A priority patent/BR112013009807A2/pt
Priority to EP11787597.1A priority patent/EP2630157B1/fr
Priority to KR1020137012930A priority patent/KR101878899B1/ko
Priority to US13/880,488 priority patent/US9556424B2/en
Priority to JP2013534197A priority patent/JP6327856B2/ja
Priority to UAA201306199A priority patent/UA112763C2/uk
Priority to CA2815264A priority patent/CA2815264A1/fr
Priority to EA201390592A priority patent/EA028761B1/ru
Priority to CN201180061600.3A priority patent/CN103429612B/zh
Publication of EP2444416A1 publication Critical patent/EP2444416A1/fr
Priority to ZA2013/02751A priority patent/ZA201302751B/en
Priority to JP2016229071A priority patent/JP2017060512A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/20—Brassicaceae, e.g. canola, broccoli or rucola
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/82—Solanaceae, e.g. pepper, tobacco, potato, tomato or eggplant
    • A01H6/823—Nicotiana, e.g. tobacco
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
    • A01H6/88—Vitaceae, e.g. Vitus [grape]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1022—Transferases (2.) transferring aldehyde or ketonic groups (2.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
    • C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y202/00—Transferases transferring aldehyde or ketonic groups (2.2)
    • C12Y202/01—Transketolases and transaldolases (2.2.1)
    • C12Y202/01007—1-Deoxy-D-xylulose-5-phosphate synthase (2.2.1.7)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Definitions

  • This invention relates to a new polypeptide having an enhanced 1-deoxy-D-xylulose 5-phosphate synthase (DXS) activity compared to typical plant or bacteria DXS proteins.
  • This polypeptide is responsible for a massive accumulation of terpenes in cells.
  • the invention also relates to transgenic plants, bacteria or yeast that express this polypeptide, and are capable of a greatly enhanced accumulation of terpenes, in comparison to plants, bacteria or yeast expressing a typical DXS gene.
  • the invention also relates to a method of production of terpenes by culturing transgenic plants, bacteria or yeast that express this polypeptide.
  • the invention relates to transgenic plants that express this polypeptide, and are resistant to clomazone.
  • Isoprenoids also known as terpenoids or terpenes
  • terpenoids are considered to be the largest family of natural products occurring in nature, with over 29 000 individual compounds identified to date. Chemically, they are extremely diverse in their structure and complexity. Isoprenoids are involved in numerous fundamental biological functions and therefore, they are essential for the normal growth and developmental processes in all living organisms.
  • isoprenoids include eukaryotic membrane stabilizers (sterols), animal and plant hormones (steroids, retinoids, gibberellins and abscisic acid), pigments for photosynthesis (carotenoids and phytol side chain of chlorophyll), and carriers for electron transport (menaquinone, plastoquinone and ubiquinone).
  • isoprenoids are a large, diverse group of complex natural products with considerable commercial interest.
  • Isoprenoids are today mostly extracted from plants or chemically synthesized to be used as pharmaceuticals (e.g. taxol, bisabolol, , and artemisinin), animal feed supplements and food colorants (various carotenoids such as lycopene and ⁇ -carotene) or flavors and fragrances (e.g. menthol, patchoulol, and nootkatone).
  • Isoprenoids are classified into groups according to the number of carbons they contain; the major groups of interest are monoterpenes (C 10 ), sesquiterpenes ( C 15 ), diterpenes ( C 20 ), and triterpenes (C 30 ).
  • IPP isopentenyl diphosphate
  • the first intermediate of the MEP pathway is 1-deoxyxylulose-5-phosphate (DXP), whose biosynthesis from glyceraldehyde-3-phosphate (G3P) and pyruvate is catalyzed by the thiamine-dependent enzyme 1-deoxyxylulose-5-phosphate synthase (DXS).
  • DXS has been shown to catalyze a rate-limiting step in the formation of isoprenoids in bacteria and in plants. Indeed, in Arabidopsis thaliana and tomato (Lycopersicon esculentum), the over-expression of DXS resulted in elevated levels of plastid-derived isoprenoids like carotenoids. This is also the case in aromatic plants such as spike lavender (Lavandula latifolia), where the over-expression of DXS led to a substantial increase in essential oil production.
  • Terpenoids are involved in aromas and fragrances of many plant-derived products, and, among them, monoterpenols contribute strongly to the aroma profiles of table grapes and wines.
  • Floral flavors described as rose or lily of the valley are related to the presence of molecules such as linalool, geraniol, nerol, alpha-terpineol or citronellol. The highest concentrations of these molecules are found in varieties of the "Muscat" group or in Gewurztraminer, leading to very characteristic aromas in these varieties. Floral flavors have appeared spontaneously in genotypes not related to the Muscat group.
  • diterpenoids have been commercially exploited, particularly in the pharmaceutical sector. This is true in particular for diterpenoids from the taxane class, paclitaxel and docetaxel, used in the treatment of breast and ovarian cancer.
  • Paclitaxel is a natural molecule extracted from the yew (Taxus sp.), while docetaxel is a semi-synthetic molecule, derived from a paclitaxel precursor, 10-deacetyl baccatin III (or 10-DAB III), also extracted from yew.
  • 10-DAB III 10-deacetyl baccatin III
  • Most of the paclitaxel biosynthetic genes of yew have been described. These molecules are costly to produce due to the relatively low abundance of 10-DAB III and especially of paclitaxel in yew extracts, and due to the absence of a synthetic method that can be scaled up industrially, on account of the structural complexity of the molecules.
  • Metabolic engineering of microorganisms for isoprenoid production may lead to production of large amounts of isoprenoids from cheap carbon sources in fermentation processes, and thereby solve many of the current problems in industrial isoprenoid production, whilst allowing for biotechnological exploitation of the large diversity found in the isoprenoid group of natural compounds.
  • isoprenoid products have been produced by genetically engineered microorganisms, including limonene, carotenoids, epi-cedrol, taxadiene, and others.
  • limonene a number of isoprenoid products
  • the genes dxs encoding DXP synthase
  • dxr DXP reductoisomerase
  • idi IPP isomerase
  • a further increase in amorphadiene production by E coli has been obtained by expressing the mevalonate pathway from Saccharomyces cerevisiae in an amorphadiene producing strain of E. coli:
  • Some isoprenoid compounds have also been produced in yeasts, including epi-cedrol in S. cerevisiae, lycopene and beta-carotene in S . cerevisiae and Candida utilis
  • isoprenoid production in yeast has been shown to be enhanced by overexpression of HMG1 (encoding HMG-COA reductase) (reviewed in MAURY et al, 2005).
  • the production of terpenes by such a microorganism is preferably stable over time.
  • an objective of the present invention is to engineer plants with enhanced isoprenoid production with an aim to purify the isoprenoid component, as a means of increasing the nutritional value of food crops, or to enhance the fitness of the plant itself by increasing resistance to herbivores, pests or pathogens
  • the present invention seeks to overcome these and other drawbacks inherent in the prior art by providing transgenic plants, bacteria or yeast that express one of these two genes, and are capable of a greatly enhanced accumulation of terpenes, in comparison to plants, bacteria or yeast expressing a typical dxs gene.
  • a first object of the invention relates to a method of enhancement of the 1-deoxy-D-xylulose 5-phosphate synthase (DXS) activity of plants or bacteria to increase terpenes production comprising the steps of:
  • the reference sequence is selected from the group comprising SEQ ID N°4, SEQ ID N°6, SEQ ID N°19 and SEQ ID N°20.
  • SEQ ID N°4 or SEQ ID N°6 are used as reference sequences for determining a mutation site on a plant polypeptide and SEQ ID N°19 or SEQ ID N°20 are used as reference sequences for determining a mutation site on a bacteria polypeptide.
  • the amino acids corresponding to K284 and R306 in the DXS from Vitis vinifera can be identified in a DXS protein from another organism using a multiple sequence alignment computer program, such as ClustalW (Thompson et al., 1994) or MUSCLE (Edgar, 2004).
  • the terms "enhancement of DXS activity" and “enhanced DXS” refer to a modified DXS according to the present invention that permit to increase terpenes production and/or accumulation in a host cell, for example plant, bacteria or yeast, transformed by this modified DXS in comparison to a host cell expressing a typical DXS gene.
  • typical DXS gene is the gene appearing at high frequency, for example the wild type of DXS MoDXS1, also known as SEQ ID N°8.
  • mutation corresponds to any modification in the sequence of the original nucleic acid sequence.
  • These mutations comprise small-scale mutations, or large scale mutations.
  • Small scale mutations are those affecting a gene in one or a few nucleotides, including point mutations, insertions or deletions of one or more extra nucleotides in the DNA. Point mutations can be silent, missense and nonsense mutation.
  • Large scale mutation in the genomic structure such as gene duplications, deletions, or mutations whose effect is to juxtapose previously separate pieces of DNA, potentially bringing together separate genes to form functionally distinct fusion genes.
  • These last mutations include chromosomal translocations, interstitial deletions, chromosomal inversions and loss of heterozygosity.
  • the present mutation is a point mutation.
  • Point mutations are individual substitutions, deletions or additions which alter, add or delete a single amino acid or a small percentage of amino acids (typically less than 5%, more typically less than 4%, 2% or 1%, or less).
  • mutant site refers to the locus of the polynucleotide represented by one or several nucleotide that is subject to a mutation as described previously.
  • site-directed mutagenesis can be performed using the QuikChange kit (Stratagene, La Jolla, CA) Site-directed mutagenesis methods have also been described by Zoller & Smith (1982) "Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any DNA fragment" Nucleic Acids Res. 10:6487-6500
  • the expression "increase terpenes production” means that the amount of terpene produced and/or accumulated in a host cell, for example plant, bacteria or yeast, transformed by this modified DXS is higher than the amount of terpene produced and/or accumulated in a host cell expressing the typical DXS gene.
  • terpene production according to the present invention is increased by a factor ten.
  • the mutation K234 ⁇ C introduced in the polynucleotide encoding the DXS enzyme of E . coli permits to increase the terpene production by at least a factor ten.
  • a second object of the invention relates to a polypeptide of plant or bacteria, having an enhanced DXS activity compared to the typical DXS of said plant or bacteria, likely to be obtained by the method of the present invention.
  • a third object of the invention relates to an isolated polypeptide having a DXS activity, which comprises a sequence having at least 90 % identity with the sequence SEQ ID N°21 or fragments thereof, wherein the amino acid at position 213 of SEQ ID N°21 is an asparagine and/or the amino acid at position 234 of SEQ ID N°21 is a cysteine.
  • SEQ ID N°21 is a consensus of bacterial DXS sequences including Deinococcus radiodurans, which has often been characterized in the literature.
  • the isolated polypeptide of the invention has the sequence SEQ ID N°22 or fragments thereof, wherein the amino acid at position 213 of SEQ ID N°22 is an asparagine and/or the amino acid at position 234 of SEQ ID N°22 is a cysteine.
  • SEQ ID N°22 is a consensus of bacterial DXS sequences characterized in that it is similar to SEQ ID N°21 except that it doesn't encompass the DXS sequence of D . radiadurans
  • polypeptide of the invention comprises the sequence SEQ ID N° 19.
  • polypeptide of the invention comprises the sequence SEQ ID N° 20.
  • a fourth object of the invention relates to an isolated polypeptide having a deoxy-D-xylulose synthase (DXS) activity, which comprises a sequence having at least 90 % identity with the sequence SEQ ID N° 1 or fragments thereof, wherein the amino acid at position 310 of SEQ ID N°1 is a cysteine and/or the amino acid at position 288 of SEQ ID N°1 is an asparagine.
  • DXS deoxy-D-xylulose synthase
  • amino acid and “amino acids” refer to all naturally occurring L-a-amino acids or their residues.
  • the amino acids are identified by either the single-letter or three-letter designations (Asp D aspartic acid; Ile I isoleucine; Thr T threonine; Leu L leucine ; Ser S serine ; Tyr Y tyrosine; Glu E glutamic acid; Phe F phenylalanine; Pro P proline; His H histidine; Gly G glycine; Lys K lysine; Ala A alanine; Arg R arginine; Cys C cysteine; Trp W tryptophan; Val V valine; Gln Q glutamine; Met M methionine; Asn N asparagine).
  • natural amino acids may be also replaced by chemically modified amino acids.
  • chemically modified amino acids enable to increase the polypeptide half life.
  • DX5 1-deoxy-D-xylulose 5-phosphate synthase
  • GAP glyceraldehyde-3-phosphate
  • the isolated polypeptide of the invention comprises a sequence having at least 90% amino acids sequence identity with the polypeptide sequence SEQ ID N°2 or fragments thereof, wherein the amino acid at position 306 of SEQ ID N°2 is a cysteine and/or the amino acid at position 284 of SEQ ID N°2 is an asparagine.
  • the polypeptide of the invention has an enzymatic activity, which is at least 50% superior as compared to the polypeptide SEQ ID N°3, preferably at least 70%, and most preferably at least 100% superior as compared to SEQ ID N°3.
  • polypeptide of the invention comprises the sequence SEQ ID N° 4.
  • polypeptide of the invention comprises the sequence SEQ ID N° 6.
  • percentage of identity between two amino acids sequences, means the percentage of identical amino-acids, between the two sequences to be compared, obtained with the best alignment of said sequences, this percentage being purely statistical and the differences between these two sequences being randomly spread over the amino acids sequences.
  • best alignment or “optimal alignment” means the alignment for which the determined percentage of identity (see below) is the highest. Sequences comparison between two amino acids sequences are usually realized by comparing these sequences that have been previously aligned according to the best alignment; this comparison is realized on segments of comparison in order to identify and compare the local regions of similarity.
  • the identity percentage between two sequences of amino acids is determined by comparing these two sequences optimally aligned, the amino acids sequences being able to comprise additions or deletions in respect to the reference sequence in order to get the optimal alignment between these two sequences.
  • the percentage of identity is calculated by determining the number of identical position between these two sequences, by dividing this number by the total number of compared positions, and by multiplying the result obtained by 100 to get the percentage of identity between these two sequences.
  • the polypeptide of the invention has an identity of at least 95%, preferably of at least 99%, and most preferably of 100% with the amino acids sequences SEQ ID N°1 or SEQ ID N°2.
  • a fragment of SEQ ID N°1 or SEQ ID N°2 refers to a polypeptide having a length of at least 300 amino acids, preferably having a length of at least 400 amino acids, more preferably having a length of at least 500 amino acids.
  • a fragment of SEQ ID N°1 or SEQ ID N°2 with a DXS activity one can cite SEQ ID N°5 corresponding to truncated MODX52 polypeptide, or SEQ ID N°7 corresponding to truncated GWDXS2 polypeptide.
  • a consensus of plant DXS sequence is SEQ ID N°23. It comprises the sequence of DXS of V . vinifera (Mo_DXS1), and the sequence of DXS of A. thaliana, P. densiflora, C reinhardtii and D. salina.
  • a fifth object of the invention relates to an isolated polynucleotide encoding for a polypeptide according to the present invention.
  • the polynucleotide of the present invention may be in the form of RNA or in the form of DNA, preferably in the form of DNA.
  • the DNA may be double-stranded or single-stranded.
  • the polynucleotide comprises a sequence selected in the group comprising SEQ ID N° 9 (MODXS2), SEQ ID N° 10 (GWDXS2), SEQ ID N° 15 (E.coli DXS-K213N) and SEQ ID N°16 (E.coli DXS-K234C).
  • a sixth object of the invention relates to a vector comprising the polynucleotide according to the present invention.
  • Said vector can be a cloning or an expression vector, preferably an expression vector, and may be for example in the form of a plasmid, a cosmid, a phagemid, a viral particle, a phage, etc.
  • Such vectors may include bacterial plasmids, phage DNA, baculovirus, yeast plasmids, vectors derived from combinations of plasmids and phage DNA, viral DNA such as vaccinia, adenovirus, fowl pox virus, and pseudorabies.
  • viral DNA such as vaccinia, adenovirus, fowl pox virus, and pseudorabies.
  • suitable vectors are known to those of skill in the art and are commercially available. The following vectors are provided by way of example.
  • Bacterial pQE70, pQE60, pQE-9 (QIAGEN), pbs, pD10, phagescript, psiX174, pbluescript SK, pbsks, pNH8A, pNH16a, pNH18A, pNH46A (STRATAGENE), ptrc99a, pKK223-3, pKK233-3, pDR540, pRIT5 (PHARMACIA).
  • Eukaryotic pWLNEO, pSV2CAT, pOG44, pXT1, pSG (STRATAGENE), p5VK3, pBPV, pMSG, pSVL (PHARMACIA).
  • any other vector may be used as long as it is replicable and viable in the host.
  • the polynucleotide sequence preferably the DNA sequence in the expression vector is operatively linked to an appropriate expression control sequence(s) (promoter) to direct mRNA synthesis.
  • promoter an appropriate expression control sequence(s)
  • prokaryotic or eukaryotic promoters such as CMV immediate early, HSV thymidine kinase, early and late SV40, LTRs from retrovirus, and mouse metallothionein-I.
  • the expression vector also contains a ribosome binding site for translation initiation and a transcription vector.
  • the vector may also include appropriate sequences for amplifying expression.
  • the expression vectors preferably contain one or more selectable marker genes to provide a phenotypic trait for selection of transformed host cells such as dihydrofolate reductase or neomycin resistance for eukaryotic cell culture, or such as tetracycline or ampicillin resistance in E . coli.
  • the vector of the invention containing the appropriate polynucleotide sequence as herein above described, as well as an appropriate promoter or control sequence, may be employed to transform an appropriate host to permit the host to express the polypeptide.
  • transcription of a DNA encoding for the polypeptide described previously by higher eukaryotes can be increased by inserting an enhancer sequence into the vector.
  • Enhancers are cis-acting elements of DNA, usually about from 10 to 300 pb that act on a promoter to increase its transcription. Examples of enhancer include the SV40 enhancer, the CMV early promoter enhancer, and adenovirus enhancers.
  • a seventh object of the invention relates to a transformed host cell comprising the polynucleotide or the vector described previously.
  • transformed host cell refers to the introduction of DNA into a cell.
  • the cell is termed a "host cell”, and it may be a prokaryotic or a eukaryotic cell.
  • Typical prokaryotic host cells include various strains of E. coli
  • Typical eukaryotic host cells are plant cells, such as maize cells, yeast cells, insect cells or animal cells. The selection of an appropriate host is deemed to be within the scope of those skilled in the art from the teachings herein.
  • the transformed host cell according to the present invention is a prokaryotic or an eukaryotic cell.
  • the introduction of the polynucleotide or vector described previously into the host cell can be effected by method well known from one of skill in the art such as calcium phosphate transfection, DEAE-Dextran mediated transfection, or electroporation.
  • the transformed host cell according to the present invention is a prokaryotic cell selected in the group comprising eubacterial, archaebacterial and cyano-bacterial cells.
  • the transformed host cell according to the present invention is a prokaryotic cell and even more preferably is an Escherichia coli cell.
  • Prokaryotes may also be used as host cells for the initial cloning steps of this invention. They are particularly useful for rapid production of large amounts of DNA, for production of single-stranded DNA templates used for site-directed mutagenesis, for screening many mutants simultaneously, and for DNA sequencing of the mutants generated.
  • Suitable prokaryotic host cells include E. coli K12 strain 94 (ATCC No. 31,446), E. coli strain W3110 (ATCC No. 27,325) E. coli X1776 (ATCC No. 31,537), and E. coli B; however many other strains of E.
  • coli such as HB101, JM101, NM522, NM538, NM539, and many other species and genera of prokaryotes including bacilli such as Bacillus subtilis, other enterobacteriaceae such as Salmonella typhimurium or Serratia marcesans, and various Pseudomonas species may all be used as hosts.
  • bacilli such as Bacillus subtilis
  • enterobacteriaceae such as Salmonella typhimurium or Serratia marcesans
  • Pseudomonas species may all be used as hosts.
  • the transformed host cell according to the present invention is a eukaryotic cell selected in the group comprising animal, fungal, yeast, and plant cells.
  • the eukaryotic cell is a fungal microorganism, more particularly a yeast.
  • a non-exhaustive list of suitable microorganisms will include the following: a species belonging to the genera Saccharomyces -e.g. S. cerevisiae, S. bayanus, S. pastorianus, S. paradoxus, S. exiguous, S. servazzi; S. uvarum, S. kluyveri, and S . castellii-, a species belonging to the genera Kluyveromyces -e.g. K. lactis, K marxianus var. marxianus, K. thermotolorens, K. waltii, K. delphensis, K. nonfermentas, and K. wickerhamii- a species belonging to the genera Candida -e.g.
  • C. utilis, C. tropicalis, C. costellii, and C. humilis- a species belonging to the genera Zygosaccharomyces -e.g. Z. rouxii Z. bailii, Z fermentati, Z bisporus, and Z florentinus- , a species belonging to the genera Pichia-e.g. P. stipidis, P. pastoris, P. sorbithophila, and P. anomala-, or other species -e.g.
  • Hansenula polymorpha Yarrowia lipolytica, Debaromyces hansenii Schizosaccharomyces pombe, Torulaspora delbueckii, Ashbya gossipie, Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Aspergillus nidulans, Penecillium chrysogenum, Rhizopus oryzae, and Mucor circenelloides-.
  • the eukaryotic cell is yeast and even more preferably, the microorganism is Saccharomyces cerevisiae.
  • Saccharomyces cerevisiae is the S . cerevisiae strain deposited at DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH. Mascheroder Weg 1b, D-38124 Braunschweig, Germany, accession number: DSMZ 17900, on Jan. 27, 2006.
  • a heterologous pathway for the purpose of the present invention, is a pathway which, in its activity to form a compound by defined intermediate steps and from defined starting materials, is not present in the wild-type of the microorganism. More preferably, the heterologous pathway is a pathway derived from DNA of a different species.
  • the eukaryotic cell is a plant cell, more preferably a plant cell selected in the group comprising Vitis vinifera, Nicotiana tabacum, and Arabidopsis thaliana cells, even more preferably said plant cell is a Vitis vinifera cell, preferably a Vitis vinifera Cv Muscat Ottonel or a Vitis vinifera Cv Gewurztraminer cell, more preferably a Vitis vinifera Cv Gewurztraminer cell.
  • An eighth object of the invention relates to a transgenic bacterium comprising the polynucleotide or the vector described previously.
  • a ninth object of the invention relates to a transgenic plant comprising the polynucleotide, the vector or the host cell described previously.
  • transgenic plants can be obtained, for example, by transferring vector of the present invention (i.e. encoding 1-deoxyxylulose-5-phosphate synthase) and a selectable marker gene (e.g., the kan gene encoding resistance to kanamycin) into Agrobacterium tumifaciens containing a helper Ti plasmid as described in HOECKEMA et al. (Nature, 303:179-181, 1983 ) and culturing the Agrobacterium cells with leaf slices, or other tissues or cells, of the plant to be transformed as described by AN et al.
  • vector of the present invention i.e. encoding 1-deoxyxylulose-5-phosphate synthase
  • a selectable marker gene e.g., the kan gene encoding resistance to kanamycin
  • Transformed plant calli may be selected through the selectable marker by growing the cells on a medium containing, e.g., kanamycin, and appropriate amounts of phytohormone such as naphthalene acetic acid and benzyladenine for callus and shoot induction.
  • the plant cells may then be regenerated and the resulting plants transferred to soil using techniques well known to those skilled in the art.
  • the transgenic plant of the invention has incorporated into its genome a polynucleotide or a vector as described previously.
  • said plant is selected in the group comprising trees, vegetables, succulents and ornamental plants.
  • said transgenic plant is resistant to clomazone also called dimethazone (FMC 57020; 2-(2-chlorophenyl)methyl-4,4-dimethyl-3-isoxalidinone).
  • FMC 57020 dimethazone
  • 2-(2-chlorophenyl)methyl-4,4-dimethyl-3-isoxalidinone 2-(2-chlorophenyl)methyl-4,4-dimethyl-3-isoxalidinone
  • transgenic plant which is resistant to clomazone corresponds to a plant which grows in the presence of 10 ⁇ M clomazone ( Carretero-Paulet L, Cairó A, Botella-Pavia P, Besumbes O, Campos N, Boronat A, Rodr ⁇ guez-Concep Terms M. (2006) Enhanced flux through the methylerythritol 4-phosphate pathway in Arabidopsis plants overexpressing deoxyxylulose 5-phosphate reductoisomerase. Plant Mol Biol 62: 683-95 ).
  • said transgenic plant has enhanced aromas.
  • said transgenic plant is selected in the group comprising Lamiaceae (e.g Ocimum (basil), Lavandula (Lavender), Origanum (oregano), Mentha (mint), Salvia (sage), Rosmecinus (rosemary), Thymus (thyme), Satureja and Monarda); Umbelliferae (e.g. Carum (caraway), Anethum (dill), feniculum (fennel) and Daucus (carrot)); Asteraceae (Compositae) (e.g.
  • Lamiaceae e.g Ocimum (basil), Lavandula (Lavender), Origanum (oregano), Mentha (mint), Salvia (sage), Rosmecinus (rosemary), Thymus (thyme), Satureja and Monarda
  • Umbelliferae e.g. Carum (caraway), Anethum (dill), feniculum (fennel
  • Artemisia tarragon, sage brush, and Tanacetum (tansy)
  • Rutaceae e.g., citrus plants
  • Rosaceae e.g., roses
  • Myrtaceae e.g., eucalyptus, Melaleuca
  • the Gramineae e.g., Cymbopogon (citronella)
  • Geranaceae e.g.,ium
  • certain conifers including Abies (e.g., Canadian balsam), Cedrus (cedar) and Thuja and Juniperus.
  • a tenth object of the invention relates to a progeny of any generation of the transgenic plant of the present invention, said progeny comprising the polypeptide -, the polynucleotide -, the vector -, or the host cell described previously.
  • Said progeny can have the form of a plant or of a seed.
  • An eleventh object of the invention relates to a method of preparing a transgenic plant as described previously, comprising the steps of:
  • the method of the invention is for obtaining a transgenic plant which is resistant to clomazone.
  • said transgenic plant is obtained by well known methods such as those described in Klee H, Horsch R, Rogers S (1987) Agrobacterium-Mediated Plant Transformation and its Further Applications to Plant Biology. Annual Review of Plant Physiology 38, 467-486 and Potrykus I (1991) Gene Transfer to Plants: Assessment of Published Approaches and Results. Annual Review of Plant Physiology and Plant Molecular Biology 42, 205-225 .
  • the method of the invention is for obtaining a transgenic plant which has enhanced terpene biosynthetic capabilities.
  • a plant with enhanced terpene biosynthetic capabilities will synthesis a least 50% more of terpenes as compared to the wild type of said transgenic plant, preferably at least 70%, more preferably at least 100%.
  • terpene relates to geraniol, linalol, citronellol, nerol and alpha-terpineol.
  • the polypeptide of the invention has an enzymatic activity, which is at least 50% superior as compared to the polypeptide SEQ ID N°3, preferably at least 70%, and most preferably at least 100% superior as compared to SEQ ID N°3.
  • Said plant having terpene biosynthetic capabilities may be aromatic plants as for example Mentha piperita, Lavandula latifolia, or Rosmarinus officinalis and medicinal plants, as for example Artemisia annua, Taxus baccata, Catharanthus roseus, or Lithospermum erythrorhizon as well as any plant species producing valuable terpene compounds, as for example plants producing carotenoids, as Lycopersicon esculentum, Manihot esculenta, or Oryza sativa.
  • said transgenic plant is selected by well known methods such as those described in Klee et al. (1987) and Potrykus (1991).
  • a twelfth object of the invention relates to a method of production of enhanced DXS enzyme which increases terpenes production in plants, bacteria or yeast comprising the following steps:
  • the polypeptide having an enhanced DXS activity is likely to be obtained by the method described previously.
  • a thirteenth object of the invention relates to a method of production of terpenes in a host cell comprising the steps of:
  • a terpene is a saturated or unsaturated, optionally substituted hydrocarbon based on, or composed essentially of, isoprene units (C 5 ).
  • Terpenes may be acyclic or cyclic.
  • Terpenes, as used herein include terpenes, terpene derivatives, and compounds referred to as terpenoids, which may or may not fall in one of the two foregoing classes of compounds.
  • Terpene derivatives include compounds that have undergone one or more steps of functionalization such as hydroxylations, isomerizations, oxido-reductions or acylations, for example.
  • a terpene is a compound which fulfils the above condition and/or whose carbon skeleton originates, at least in part but preferably totally, from the MEP and/or MEV pathway.
  • terpenes include terpene alcohols, for example C 15 H 26 O and C 10 H 18 O compounds such as patchoulol, epi-cedrol, cubebol, linalool, nerolidol, for example, and dialcohols, for example sclareol.
  • Terpenes also include diphosphate compounds such as bornyl-diphosphate (monoterpene) and copalyl-diphosphate (diterpene), just to mention a few specimens of the vast category of terpenes.
  • a “derivative” is any compound obtained from a known or putative compound and containing essential elements of the parent substance.
  • terpenes are compounds having carbon skeletons of C 10 , C 15 , C 20 , C 30 , C 40 , C 45 and so forth.
  • terpene encompasses mono, sesqui, di, tri, tetra and/or polyterpenes.
  • said terpenes comprise geraniol, linalol, citronellol, nerol and alpha-terpineol.
  • the microorganism of the invention provides a yield of at least 30 ⁇ g, more preferably at least 100 ⁇ g of terpene per g fresh-weight of the microorganism.
  • the terpene yield of a microorganism is preferably established by the protocol in Example 2.
  • the terpenes may accumulate in the cells. For example, they may accumulate in the cytoplasm, in mitochondria, cellular membranes or other cell organelles. Many terpenes are lipophilic compounds, which accumulate in the plasma membrane of the cell.
  • the term "accumulating in the medium” also encompasses accumulation in a solvent during a two-phase fermentation process.
  • the method comprises the step of cultivating the transformed host cell under conditions conducive to the production of said terpene. These conditions are known to the skilled person. Generally, they may be adjusted by selection of an adequate medium, fermentation vessel, temperature, and pH.
  • the method for producing a terpene may comprise the step of isolating the terpene from the medium, from the cells and/or from an organic solvent, in case a two-phase fermentation is performed.
  • the terpene may be isolated by any method used in the art including but not limited to chromatography, extraction and distillation, for example.
  • microbes In contrast to plants, microbial systems are more amenable to large-sale engineering projects where many different modifications may be compared and combined. However, microbes do suffer some technical drawbacks compared with plants, particularly when it comes to expressing heterologous genes.
  • a fourteenth object of the invention relates to a method of selecting an aromatic plant comprising the steps of:
  • a fifteenth object of the invention relates to a method of producing a DXS enzyme which are more resistant to clomazone comprising the steps of:
  • DXS cDNAs from Vitis vinifera cv Muscat Ottonel (MO) and Gewurztraminer (Gw) were amplified using RT-PCR and cloned. Sequencing of these clones revealed that both MO and Gw are heterozygous at the DXS locus. MO and Gw share the same allele designated MoDXS1 ( Fig. 1 ). In addition, Mo and Gw possess the MoDXS2 and GwDXS2 alleles, respectively. MoDXS2 and GwbXS2 alleles differ from MoDXS1 in 2 and 1 SNP, respectively, which modify the amino-acid sequence of the corresponding proteins ( Fig. 2 ).
  • the K284 ⁇ N and R306 ⁇ C mutations affect amino-acids that are conserved in all plant DXS sequences available in databases ( Fig 3 ). Furthermore, the amino-acids K284 and R306 belong to the active site of the enzyme (Xiang et al., 2007), indicating that they may modify the activity of the MoDXS2 and GwDXS2 alleles, in comparison to MoDXS1.
  • terpenol analysis was performed for each sampling point. For each replicate, at least 25 berries were used. Seeds were removed and skins separated from mesocarps. After weighing, skins were ground under liquid nitrogen and then suspended in 40 mL of water after addition of 40 mg of sodium sulphite. The supernatant obtained after a 15-min centrifugation (11400 g at 4°C) was passed through a glass fibre pre-filter and a glass filter. Twenty microlitres of a 1 g/L 4-nonanol solution was added as external standard to allow the quantification of the main terpenols. Extraction of terpenols was adapted from Mateo et al.
  • This total terpenol extract was diluted in 40 mL of citrate/phosphate buffer (pH 4.5) and the resulting solution was incubated with 50 mg of AR2000 glycolytic enzyme (Gist-Brocades, Seclin, France) overnight at 37.5°C to release the glycosidically bound terpenols (Tamborra et al. 2004).
  • the released terpenols were separated by SPE on a C18 column and eluted with 4 mL of dichloromethane after rinsing with 3x 5 mL water.
  • the hydrolysis step was not performed and terpenols were directly eluted with dichloromethane after rinsing with water.
  • Extracts were dried in Pasteur pipettes filled with 0.5 g of anhydrous sodium sulphite and concentrated to 500 ⁇ L under a gentle nitrogen flux, Twenty microlitres of a 1 g/L solution of m-cresol was added to each sample as internal control. Samples were stored at -20°C prior to gas chromatography (GC) analysis.
  • GC gas chromatography
  • Example 2 shows that DXS alleles have a major impact on terpenol content in grape berries, as shown by the investigation of terpenol contents as a function of DXS alleles in a MO ( Fig. 4 ) and in a GW ( Fig. 5 ) progeny.
  • GES was used as a reporter gene responsible for the biosynthesis of the monoterpenol geraniol, which normally does not accumulate in tobacco.
  • DXS activity has been shown to be limiting for terpenes biosynthesis in plants (Estevez et al., 2001; Enfissi et al., 2005)
  • the amount of geraniol formed by GES activity depended directly on DXP substrate availability, and therefore, on DXS activity in tobacco leaves.
  • GC-MS analyses of tobacco leaves co-expressing GES and DXS alleles allowed an accurate comparison of DXS alleles activity in planta.
  • Grapevine DXS cDNAs were amplified by PCR using the upstream primer 5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTTGGTTCCGCGTGGATCAATGGCTCTCTG TACGCTCTCATTTCC-3' (SEQ ID N°11) and the downstream primer 5'-GGGGACCACTTTGTACAAGAAAGCTGGGTTCACTATAACATGATCTCCAGGGCCTCC -3' (SEQ ID N°12), and cloned into the pDONR207 Gateway compatible vector (Invitrogen, Carlsbad, CA) using Gateway BP clonase (Invitrogen) according to the manufacturer's instructions. DXS cDNAs were sequenced to verify that no mutation had been introduced.
  • DXS cDNAs were subsequently transferred into the GATEWAY binary vector pMDC32 (Curtis and Grossniklaus., 2003).
  • Geraniol synthase cDNA from basilicum Ocimum basilicum ) (Ii jima et al., 2004) was cloned into the GATEWAY binary vector pMDC83 (Curtis and Grossniklaus., 2003) and expressed as a GFP fusion protein. All constructs were introduced into Agrobacterium tumefaciens strain C58 (pMP90) by electroporation. Nicotiana benthamiana leaves were infiltrated with A. tumefaciens cultures (OD600 0.5) according to Voinnet et al. (2003). Leaf sectors were and analysed for terpene content 96 h after Agrobacterium infiltration.
  • GC-MS gas chromatography and mass spectrometry
  • Agilent 6890N gas chromatograph equipped with a Gerstel MPS2 XL sampler and coupled to an Agilent 5975B inert mass spectrometer (Agilent Technologies).
  • the gas chromatograph was fitted with a DB-Wax capillary column (60 m x 0.32 mm i.d. x 0.5 ⁇ m film thickness, J&W Scientific) and helium was used as carrier gas (1 ml min-1 constant flow).
  • the GC oven temperature was programmed without initial hold time from 45°C to 82°C at a rate of 20°C min-1 (hold 1 min) then from 82°C to 235°C (hold 15 min) at a rate of 2.7°C/min.
  • the injector was set to 250°C and used in pulsed splitless mode (25 psi for 0.50 min).
  • the temperatures of the interface, MS ion source and quadrupole were 270°C, 230°C and 150°C, respectively.
  • the Mass spectrometer was operated in electron impact ionization mode (EI, 70 eV) and the masses were scanned over a m/z range of 29 - 300 amu.
  • Agilent MSD ChemStation software (G1701DA, Rev D.03.00) was used for instrument control and data processing. The mass spectra were compared with the Wiley's library reference spectral bank.
  • co-expression of GES and MoDXS2 or GwDXS2 led, in average, to a three time increase in geraniol accumulation in tobacco leaves ( Fig. 7 ), indicating that these alleles possessed an enhanced DXS activity, compared to MoDXS1.
  • the inventors conclude that the massive accumulation of terpenols in MO and GW is due to the presence of the MoDXS2 or GwDXS2.
  • the K284 ⁇ N and R306 ⁇ C mutations which affect amino-acids in the active site of the enzyme, confer an enhanced DXS activity compared to MoDXS1, which in turn is responsible for the increased accumulation of terpenes in planta.
  • the aim of the following experiments is to investigate whether the role of these mutations can be extended to DXS enzymes from other sources.
  • the inventors have selected the DXS from Escherichia coli, whose enzymatic properties are well characterized (Querol et al., 2001; Xiang et al., 2007).
  • the DXS gene from Escherichia coli was amplified by PCR using the upstream primer GGGGACAAGTTTGTACAAAAAAGCAGGCTTGGTTCCGCGTGGATCAATGAGTTTTG ATATTGCCAAATACCC (SEQ ID N°24) and the downstream primer GGGGACCACTTTGTACAAGAAAGCTGGGTTCATTATGCCAGCCAGGCCTTGATTTTG (SEQ ID N°25) and cloned into the pDONR207 Gateway compatible vector (A technology that enables rapid cloning of one or more genes.
  • the entry vector confers resistance to gentamycin)(Invitrogen, Carlsbad, CA) using BP clonase, a mixture of proteins that catalyse the in vitro recombination of PCR products or DNA segments from clones, (Invitrogen) according to the manufacturer's instructions.
  • the DXS gene was subsequently transferred into the GATEWAY- compatible expression vector pHGWA (Busso et al., 2003) using LR clonase, a mixture of enzymes that catalyse the in vitro recombination between an entry clone and a destination vector to generate the expression clone, (Invitrogen), yielding the plasmid pHGWA-EcoIiDXS.
  • This plasmid was used for site-directed mutagenesis, in order to introduce the K213 ⁇ N and the K234 ⁇ C mutations into the DXS protein form E. coli.
  • Site-directed mutagenesis was performed using the QuikChange kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions.
  • QuikChange kit is based on mutagenic primers and DNA polymerase. It is designed to help introduce single or multiple point mutations into a gene of choice to produce enzymes mutants with amino acids changes, insertions or deletions.
  • the forward primer GCGCGAAGGCGGGAACAAAGTTTTCTCTGGCGTGCC (SEQ ID N°26) and the reverse primer GGCACGCCAGAGAAAACTTTGTTCCCGCCTTCGCGC (SEQ ID N°27) were used to introduce the K213 ⁇ N mutation, yielding the plasmid pHGWA-EcoIiDXS-K213N.
  • the forward primer CGCACCGAAGAACATATTTGCGGCATGGTAGTGCCTGG SEQ ID N°28
  • the reverse primer CCAGGCACTACCATGCCGCAAATATGTTCTTCGGTGCG (SEQ ID N°29) were used to introduce the K234 ⁇ C mutation, yielding the plasmid pHGWA-EcoliDXS-K234C.
  • pHGWA-EcolibXS, pHGWA-truncated-EcoliDXS, pHGWA-EcoliDX5-K213N and pHGWA-EcoliDXS-K234C plasmids were transformed into the BL21-Gold(DE3)pLysS E. coli strain (Stratagene, La Jolla, CA).
  • BL21-Gold(DE3)pLysS E . coli strain are competent cells that provide increased transformation efficiency. They are resistant to tetracycline and chloramphenicol.
  • Transformants were grown at 28°C in 50 mL LB medium supplemented with glucose (10 g/L), in the presence of ampicillin (100 ⁇ g/mL), chloramphenicol (25 ⁇ g/mL), and tetracyclin (2 ⁇ g/mL). When the cultures reached an OD of 0.1, DXS expression was induced with 1 mM of isopropyl ⁇ -D-1-thiogalactopyranoside (IPTG) and the culture was grown for 24h.
  • IPTG isopropyl ⁇ -D-1-thiogalactopyranoside
  • MO- and GW-like mutations K213 ⁇ N and K234 ⁇ C, respectively
  • Example shows that the mutations introduced in the DXS from E. coli impact the monoterpene content in culture media ( Fig. 5 ).
  • the mutation K234 ⁇ C in the DXS from E. coli leads to a greatly enhanced accumulation of terpenes in culture media. Therefore, the inventors conclude that non-plant DXS enzymes can be modified at the positions corresponding to K284 and R306 in the DXS proteins of grapevine, in order to improve DXS activity.
  • Such improved DXS mutants may be used for the metabolic engineering of microorganisms, in order to enhance the production of isoprenoids of interest.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
EP11003842A 2010-10-20 2011-05-10 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène Withdrawn EP2444416A1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
EP11003842A EP2444416A1 (fr) 2010-10-20 2011-05-10 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène
US13/880,488 US9556424B2 (en) 2010-10-20 2011-10-20 1-deoxy-D-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis
JP2013534197A JP6327856B2 (ja) 2010-10-20 2011-10-20 向上したテルペン生合成に重要である１−デオキシ−ｄ−キシルロース−５−リン酸シンターゼ対立遺伝子
PCT/EP2011/005283 WO2012052171A1 (fr) 2010-10-20 2011-10-20 Allèles de 1-désoxy-d-xylulose 5-phosphate synthase responsables de la biosynthèse améliorée des terpènes
BR112013009807-4A BR112013009807A2 (pt) 2010-10-20 2011-10-20 método para melhorar a atividade de 1-desoxi-d-xilulose 5-fosfato sintase de plantas ou bactérias, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, bactéria transgênica, planta transgênica, método para preparar uma planta transgênica, método para produzir uma enzima de dsx melhorada, método para produzir terpeno
EP11787597.1A EP2630157B1 (fr) 2010-10-20 2011-10-20 Allèles de 1-désoxy-d-xylulose 5-phosphate synthase responsables de la biosynthèse améliorée des terpènes
KR1020137012930A KR101878899B1 (ko) 2010-10-20 2011-10-20 테르펜 생합성의 강화를 위한 1-데옥시-d-크실룰로스 5-포스페이트 신타아제 대립유전자
DK11787597.1T DK2630157T3 (en) 2010-10-20 2011-10-20 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE ALLOCALLY RESPONSIBLE FOR IMPROVED TERPEN BIOSYNTHESIS
AU2011317859A AU2011317859B2 (en) 2010-10-20 2011-10-20 1-deoxy-D-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis
UAA201306199A UA112763C2 (uk) 2010-10-20 2011-10-20 Алелі 1-дезокси-d-ксилулозо-5-фосфатсинтази, відповідальні за посилений біосинтез терпенів
CA2815264A CA2815264A1 (fr) 2010-10-20 2011-10-20 Alleles de 1-desoxy-d-xylulose 5-phosphate synthase responsables de la biosynthese amelioree des terpenes
EA201390592A EA028761B1 (ru) 2010-10-20 2011-10-20 Аллели 1-d-дезоксиксилулозо-5-фосфат синтазы, ответственные за усиленный биосинтез терпенов
CN201180061600.3A CN103429612B (zh) 2010-10-20 2011-10-20 导致萜烯生物合成增强的1-脱氧-d-木酮糖5-磷酸合酶等位基因
ZA2013/02751A ZA201302751B (en) 2010-10-20 2013-04-17 1-deoxy-d-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis
JP2016229071A JP2017060512A (ja) 2010-10-20 2016-11-25 向上したテルペン生合成に重要である１−デオキシ−ｄ−キシルロース−５−リン酸シンターゼ対立遺伝子

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10013809A EP2444415A1 (fr) 2010-10-20 2010-10-20 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène
EP11003842A EP2444416A1 (fr) 2010-10-20 2011-05-10 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène

Publications (1)

Publication Number Publication Date
EP2444416A1 true EP2444416A1 (fr) 2012-04-25

Family

ID=43513606

Family Applications (3)

Application Number Title Priority Date Filing Date
EP10013809A Withdrawn EP2444415A1 (fr) 2010-10-20 2010-10-20 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène
EP11003842A Withdrawn EP2444416A1 (fr) 2010-10-20 2011-05-10 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène
EP11787597.1A Not-in-force EP2630157B1 (fr) 2010-10-20 2011-10-20 Allèles de 1-désoxy-d-xylulose 5-phosphate synthase responsables de la biosynthèse améliorée des terpènes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10013809A Withdrawn EP2444415A1 (fr) 2010-10-20 2010-10-20 Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP11787597.1A Not-in-force EP2630157B1 (fr) 2010-10-20 2011-10-20 Allèles de 1-désoxy-d-xylulose 5-phosphate synthase responsables de la biosynthèse améliorée des terpènes

Country Status (13)

Country Link
US (1) US9556424B2 (fr)
EP (3) EP2444415A1 (fr)
JP (2) JP6327856B2 (fr)
KR (1) KR101878899B1 (fr)
CN (1) CN103429612B (fr)
AU (1) AU2011317859B2 (fr)
BR (1) BR112013009807A2 (fr)
CA (1) CA2815264A1 (fr)
DK (1) DK2630157T3 (fr)
EA (1) EA028761B1 (fr)
UA (1) UA112763C2 (fr)
WO (1) WO2012052171A1 (fr)
ZA (1) ZA201302751B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3155103A1 (fr) * 2014-06-13 2017-04-19 Deinove Procédé de production de terpènes ou de terpénoïdes

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2444415A1 (fr) * 2010-10-20 2012-04-25 Genoplante-Valor Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène
KR20150014941A (ko) * 2012-05-16 2015-02-09 글리코스 바이오테크놀로지스, 인코포레이티드 아이소프렌의 생산을 위한 미생물유기체 및 방법
WO2016108236A1 (fr) * 2014-12-29 2016-07-07 Futuragene Israel Ltd. Constructions d'acides nucléiques, plantes les comprenant et utilisations associées dans l'amélioration de la résistance des plantes aux nuisibles et la modification du profil monoterpénique des plantes
CN106148295A (zh) * 2015-04-15 2016-11-23 中国科学院微生物研究所 1-脱氧-d-木酮糖-5-磷酸合成酶及其编码基因与应用
JP6357186B2 (ja) * 2016-03-31 2018-07-11 Ｊｘｔｇエネルギー株式会社 カロテノイドの製造方法
CA3046436A1 (fr) 2016-12-16 2018-06-21 Deinove Procedes de production de phytoene
CA3084263A1 (fr) 2017-12-07 2019-06-13 Zymergen Inc. Voies de biosynthese manipulees pour la production de (6e)-8-hydroxygeraniol par fermentation
EP3728212A1 (fr) 2017-12-21 2020-10-28 Zymergen Inc. Népétalactol oxydoréductases, népétalactol synthases et microbes capables de produire une népétalactone
EP3833754A4 (fr) * 2018-08-08 2022-06-15 Board of Trustees of Michigan State University Production améliorée de terpénoïdes à l'aide d'enzymes ancrées à des protéines de surface de gouttelettes lipidiques
CN113015807A (zh) * 2018-08-31 2021-06-22 新加坡科技研究局 萜类化合物的生产方法
CN114107549A (zh) * 2021-12-14 2022-03-01 北京市林业果树科学研究院 一种与葡萄果实玫瑰香味相关的kasp分子标记与应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011757A1 (fr) * 1997-09-02 1999-03-11 Washington State University Research Foundation SEQUENCES D'ACIDES NUCLEIQUES ET AMINES, DESTINEES A UNE NOUVELLE TRANSKETOLASE EXTRAITE DE $i(MENTHA PIPERITA)
WO2000044912A1 (fr) * 1999-01-28 2000-08-03 Royal Holloway And Bedford New College Manipulation de l'expression d'un isoprenoide
GB2430200A (en) * 2005-09-16 2007-03-21 Bridgestone Corp A gene cluster involved in biosynthesis of isopentenyl diphosphate by the non-mevalonate pathway of Hevea brasiliensis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831570A1 (de) * 1998-07-14 2000-01-20 Siemens Ag Biometrischer Sensor und Verfahren zu dessen Herstellung
CN106939323B (zh) * 2005-07-05 2021-07-13 加利福尼亚大学董事会 编码类异戊烯修饰酶的多核苷酸和其使用方法
EP1987147B1 (fr) 2006-02-14 2010-07-28 Firmenich S.A. Procédé de production de terpènes et micro-organismes transformés par mep pour ce procédé
MY153871A (en) 2008-04-23 2015-03-31 Danisco Us Inc Isoprene synthase variants for improved microbial production of isoprene
EP2444415A1 (fr) * 2010-10-20 2012-04-25 Genoplante-Valor Allèles de synthase de 1-déoxy-D-xylulose 5-phosphate pour biosynthèse améliorée de terpène

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011757A1 (fr) * 1997-09-02 1999-03-11 Washington State University Research Foundation SEQUENCES D'ACIDES NUCLEIQUES ET AMINES, DESTINEES A UNE NOUVELLE TRANSKETOLASE EXTRAITE DE $i(MENTHA PIPERITA)
WO2000044912A1 (fr) * 1999-01-28 2000-08-03 Royal Holloway And Bedford New College Manipulation de l'expression d'un isoprenoide
GB2430200A (en) * 2005-09-16 2007-03-21 Bridgestone Corp A gene cluster involved in biosynthesis of isopentenyl diphosphate by the non-mevalonate pathway of Hevea brasiliensis

Non-Patent Citations (22)

* Cited by examiner, † Cited by third party
Title
AN ET AL., PLANT PHYSIOLOGY, vol. 81, 1986, pages 301 - 305
CAPECCHI, CELL, vol. 22, 1980, pages 479
CARRETERO-PAULET L, CAIRO A, BOTELLA-PAVIA P, BESUMBES 0, CAMPOS N, BORONAT A, RODRIGUEZ-CONCEPCION M: "Enhanced flux through the methylerythritol 4-phosphate pathway in Arabidopsis plants overexpressing deoxyxylulose 5-phosphate reductoisomerase", PLANT MOL SIOL, vol. 62, 2006, pages 683 - 95
DUCHENE ERIC ET AL: "A grapevine (Vitis vinifera L.) deoxy-d-xylulose synthase gene colocates with a major quantitative trait loci for terpenol content", THEORETICAL AND APPLIED GENETICS, vol. 118, no. 3, February 2009 (2009-02-01), pages 541 - 552, XP002620521, ISSN: 0040-5752, DOI: 10.1007/s00122-008-0919-8 *
EDGAR, ROBERT C., NUCLEIC ACIDS RESEARCH, vol. 32, 2004, pages 1792
HOECKEMA ET AL., NATURE, vol. 303, 1983, pages 179 - 181
JAILLON OLIVIER ET AL: "The grapevine genome sequence suggests ancestral hexaploidization in major angiosperm phyla", NATURE (LONDON), vol. 449, no. 7161, September 2007 (2007-09-01), pages 463-467 - METHODS, XP002620523, ISSN: 0028-0836, DOI: 10.1038/nature06148 *
JURI BATTILANA ET AL: "The 1-deoxy-d-xylulose 5-phosphate synthase gene co-localizes with a major QTL affecting monoterpene content in grapevine", THEORETICAL AND APPLIED GENETICS ; INTERNATIONAL JOURNAL OF PLANT BREEDING RESEARCH, vol. 118, no. 4, 27 November 2008 (2008-11-27), SPRINGER, BERLIN, DE, pages 653 - 669, XP019698334, ISSN: 1432-2242 *
KAWAI, NISHIZAWA, MOL. CELL. BIOL, vol. 4, 1984, pages 1172
KLEE H, HORSCH R, ROGERS 5: "Agrobacterium-Mediated Plant Transformation and its Further Applications to Plant Biology", ANNUAL REVIEW OF PLANT PHYSIOLOGY, vol. 38, 1987, pages 467 - 486
KUZUYAMA TOMOHISA ET AL: "CLONING AND CHARACTERIZATION OF 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE FROM STREPTOMYCES SP. STRAIN CL190, WHICH USES BOTH THE MEVALONATE AND NONMEVALONATE PATHWAYS FOR ISOPENTENYL DIPHOSPHATE BIOSYNTHESIS", JOURNAL OF BACTERIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC; US, vol. 182, no. 4, 1 February 2000 (2000-02-01), pages 891 - 897, XP009081766, ISSN: 0021-9193, DOI: 10.1128/JB.182.4.891-897.2000 *
LANGE ET AL: "A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathway", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, US, vol. 95, 1 March 1998 (1998-03-01), pages 2100 - 2104, XP002116672, ISSN: 0892-6638 *
MUNOZ-BERTOMEU JESUS ET AL: "Up-regulation of 1-deoxy-D-xylulose-5-phosphate synthase enhances production of essential oils in transgenic spike lavender", PLANT PHYSIOLOGY (ROCKVILLE), vol. 142, no. 3, November 2006 (2006-11-01), pages 890 - 900, XP002620525, ISSN: 0032-0889, DOI: 10.1104/pp.106.086355 *
NEDDLEMAN, WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443
NEUMANNET, EMBOJ, vol. 1, 1982, pages 841
PAETZOLD HEIKE ET AL: "The Isogene 1-Deoxy-D-Xylulose 5-Phosphate Synthase 2 Controls Isoprenoid Profiles, Precursor Pathway Allocation, and Density of Tomato Trichomes", MOLECULAR PLANT, vol. 3, no. 5, September 2010 (2010-09-01), pages 904 - 916, XP002620524 *
PEARSON, LIPMAN, PROC. NATL. ACD SÁ USA, vol. 85, 1988, pages 2444
POTRYKUS I: "Gene Transfer to Plants: Assessment of Published Approaches and Results", ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY, vol. 42, 1991, pages 205 - 225
SCHAFFNER, PROC. NATAL. ACAD. SCI. USA, vol. 77, 1980, pages 2163
SMITH, WATERMAN, AD APP. MATH., vol. 2, 1981, pages 482
XIANG SONG ET AL: "Crystal structure of 1-deoxy-d-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 4, January 2007 (2007-01-01), pages 2676 - 2682, XP002620522, ISSN: 0021-9258, DOI: 10.1074/jbc.m610235200 *
ZOLLER, SMITH: "Oligonucieotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any DNA fragment", NUCLEIC ACIDS RES., vol. 10, 1982, pages 6487 - 6500

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3155103A1 (fr) * 2014-06-13 2017-04-19 Deinove Procédé de production de terpènes ou de terpénoïdes

Also Published As

Publication number Publication date
CN103429612A (zh) 2013-12-04
US20130276166A1 (en) 2013-10-17
EP2630157B1 (fr) 2018-01-24
KR20140032947A (ko) 2014-03-17
UA112763C2 (uk) 2016-10-25
WO2012052171A1 (fr) 2012-04-26
AU2011317859A1 (en) 2013-05-23
EA201390592A1 (ru) 2014-01-30
CA2815264A1 (fr) 2012-04-26
AU2011317859B2 (en) 2015-07-16
JP2014500710A (ja) 2014-01-16
KR101878899B1 (ko) 2018-08-17
JP6327856B2 (ja) 2018-05-23
DK2630157T3 (en) 2018-04-30
EP2630157A1 (fr) 2013-08-28
ZA201302751B (en) 2014-09-25
EA028761B1 (ru) 2017-12-29
EP2444415A1 (fr) 2012-04-25
CN103429612B (zh) 2016-08-10
US9556424B2 (en) 2017-01-31
BR112013009807A2 (pt) 2021-06-29
JP2017060512A (ja) 2017-03-30

Similar Documents

Publication Publication Date Title
EP2630157B1 (fr) Allèles de 1-désoxy-d-xylulose 5-phosphate synthase responsables de la biosynthèse améliorée des terpènes
Abbas et al. Functional characterization and expression analysis of two terpene synthases involved in floral scent formation in Lilium ‘Siberia’
AU763068B2 (en) Nucleic acids encoding (taxus) geranylgeranyl diphosphate synthase, and methods of use
CN104004789B (zh) 用于生产β-檀香萜的方法
US20100297722A1 (en) Transgenic moss producing terpenoids
US10266837B2 (en) Terpene synthases from ylang ylang (Cananga odorata var. fruticosa)
Huang et al. Cloning and selection of carotenoid ketolase genes for the engineering of high-yield astaxanthin in plants
EP3368673B1 (fr) Compositions et procédés permettant la production de myrcène
Dueholm et al. In planta and in silico characterization of five sesquiterpene synthases from Vitis vinifera (cv. Shiraz) berries
WO2014206412A1 (fr) Production hétérologue de patchoulol, de bêta-santalène et de sclaréol dans des cellules de mousse
Zhao et al. Alcohol dehydrogenases regulated by a MYB44 transcription factor underlie Lauraceae citral biosynthesis
Heo et al. Construction of an artificial biosynthetic pathway for the styrylpyrone compound 11-methoxy-bisnoryangonin produced in engineered Escherichia coli
Borghi et al. Cloning and characterization of a monoterpene synthase gene from flowers of Camelina sativa
Perassolo et al. Biosynthesis of sesquiterpene lactones in plants and metabolic engineering for their biotechnological production
JP6748108B2 (ja) 芳香性化合物の製造
Tang et al. Cloning and functional analysis of CDS_CCI2: A Tanacetum cinerariaefolium chrysanthemyl diphosphate synthase gene
CN110951788A (zh) 马尾松α-蒎烯合成酶在制备萜烯类化合物及包含萜烯类化合物的产品中的应用
ELSHERBENY et al. MOLECULAR CLONING AND CHARACTERIZATION OF TERPENE SYNTHASE 4 (SgTPS4) GENE FROM Salvia guaranitica PLANT
JP5753052B2 (ja) テルピネオール合成酵素をコードするポリヌクレオチドおよびその用途
CN117230030A (zh) 一种生物全合成紫杉醇前体物质巴卡亭iii的方法、生物材料及应用
CN114381473A (zh) 转录因子LcERF19在调控山鸡椒精油合成中的应用

Legal Events

Date Code Title Description
AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121026